CRISPR Therapeutics Earnings Update: Maintains The Lead In Cas9 Clinical Trials – Seeking Alpha
|
CRISPR Therapeutics Earnings Update: Maintains The Lead In Cas9 Clinical Trials
Seeking Alpha CRSP’s update on their pipeline is encouraging – IND on track for 2017, first company in the CRISPR-Cas9 clinical space. Looking to address a large market with their lead product in ß-thallasemia and Sickle Cell Disease. Continuing to pay attention to … Head to Head Comparison: Crispr Theraptc (CRSP) and Editas Medicine (EDIT)Dispatch Tribunal CRISPR THERAPTC (CRSP) Announces Earnings ResultsTrueBlueTribune CRISPR Therapeutics AG (NasdaqGM:CRSP): A Look at Technicals & ValuationPearson Press |
Peninsula Daily News |
Bingo fundraises for Port Angeles woman’s stem cell therapy
Peninsula Daily News PORT ANGELES — One spaghetti feed, garage sale, GoFundMe page and donation account later, a Port Angeles woman sits less than $5,000 away from undergoing stem cell therapy for multiple sclerosis. And “Bingo!” — Jolinda Creery could reach her … |
|
300 stem cell donors feted for saving lives
The Hindu Over 300 stem cell donors were felicitated on Friday for saving lives in the past eight years. The donors were honoured by Datri, India’s largest stem cell donors’ registry, which was established in 2009 by Raghu Rajagopal. Datri has been working to … |